BioWin’s Post

BioWin is joining forces with the Oncidium foundation, an independent non-profit organisation dedicated to ensuring equal access to radioligand therapy for cancer care. Officially announced yesterday during our Annual Dinner, this partnership builds on a shared vision: to boost collaboration and innovation in nuclear medicine and radiopharmaceuticals, in Belgium and beyond. Together, BioWin and Oncidium will focus on expanding access to life-saving radioisotopes, raising awareness around their potential, and working hand in hand with public authorities, hospitals and research centres. A joint steering committee, led by David Honba (BioWin) and Efrain Perini (Oncidium Foundation), will guide and follow up on the work ahead. Sylvie Ponchaut, CEO of BioWin, said: “We are thrilled to partner with the Oncidium Foundation. Together, we will leverage Wallonia’s scientific excellence and Oncidium’s international reach to promote Belgium as a leading center for radiopharmaceutical innovation.” 👉 See the full release: https://lnkd.in/eh_XDfFA